News25/Ratings5
News · 26 weeks54+180%
2026-03-012026-08-23
Mix2990d
- Insider11(38%)
- SEC Filings9(31%)
- Leadership4(14%)
- Other4(14%)
- Analyst1(3%)
Latest news
25 items- INSIDERChief Financial Officer Lo Hoi Chun exercised 78,551 units of Class A Ordinary Share at a strike of $0.00, increasing direct ownership by 6% to 566,013 units (SEC Form 4)4 - Prenetics Global Ltd (0001876431) (Issuer)
- INSIDERChief Executive Officer Yeung Danny Sheng Wu exercised 53,953 units of Class A Ordinary Share at a strike of $0.00, disposed of 49,912 units of Class A Ordinary Share and bought $501,998 worth of Class A Ordinary Share (24,681 units at $20.34), increasing direct ownership by 34% to 112,416 units (SEC Form 4)4 - Prenetics Global Ltd (0001876431) (Issuer)
- SECSEC Form S-8 filed by Prenetics Global LimitedS-8 - Prenetics Global Ltd (0001876431) (Filer)
- SECSEC Form 6-K filed by Prenetics Global Limited6-K - Prenetics Global Ltd (0001876431) (Filer)
- PRPrenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership— Lily is IM8’s first Global Ambassador from film and television, extending a roster built in elite sport into global entertainment and culture — Lily brings a following of more than 33 million across social platforms and an engagement rate of approximately 5.9%, several times the benchmark for accounts of comparable scale — Partnership lands as Prenetics raises FY 2026 revenue guidance to $220+ million; Initiates FY 2027 revenue guidance of $400+ million — Joins an equity-aligned roster of David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, Jay Shetty and Inter Miami CF NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or
- SECSEC Form 6-K filed by Prenetics Global Limited6-K - Prenetics Global Ltd (0001876431) (Filer)
- PRPrenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and BeyondTotal revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company’s guidance of $46-48 millionIM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company’s guidance of $44-46 million, marking the sixth consecutive record quarterJuly: strongest month ever at IM8 with $20.9 million — $251 million annualized revenue run-rateInitiates FY2027 guidance of $400 million+ in IM8 revenue Webcast Information Prenetics will host a live earnings webcast at 8:30 a.m. Eastern time today to discuss the results. To join, please visit https://stocktwits.com/symbol/PRE. A replay will be made available on the Investor Relations website following the call. NEW YORK, Aug. 18, 2026 (GLOBE NE
- SECSEC Form 6-K filed by Prenetics Global Limited6-K - Prenetics Global Ltd (0001876431) (Filer)
- PRPrenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director30+ years as one of Wall Street’s top-ranked equity research consumer analysts, including leadership of U.S. consumer research at UBSCaroline will also serve on the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.Prenetics will report its second quarter 2026 financial results tomorrow, Tuesday, August 18, 2026, and will host a live earnings webcast at 8:30 a.m. Eastern time on StockTwits. CEO Danny Yeung and CFO Brian Rosin will present Q2 results and outlook, with newly appointed independent director Caroline Levy and founding Scientific Advisory Board member Dr. Dawn Mussallem, followed by live Q&A with research analysts. To join, please visit http
- INSIDERSEC Form 3 filed by new insider Tat Thuan Yen3 - Prenetics Global Ltd (0001876431) (Issuer)
- SECAmendment: SEC Form F-1/A filed by Prenetics Global LimitedF-1/A - Prenetics Global Ltd (0001876431) (Filer)
- SECSEC Form 6-K filed by Prenetics Global Limited6-K - Prenetics Global Ltd (0001876431) (Filer)
- PRPrenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference ParticipationNEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today announced it will release financial results for the second quarter 2026 ended June 30, 2026 before market open on Tuesday, August 18, 2026. Beginning this quarter, Prenetics is enhancing how it communicates its financial results. In place of a traditional earnings press release, the Company will publish a detailed shareholder letter and an accompanying investor deck on its investor relations website at https://ir.prenetics.com/, providing shar
- INSIDERDirector Leogrande Hudson Blake converted options into 2,001 units of Class A Ordinary Share, increasing direct ownership by 100% to 4,001 units (SEC Form 4)4 - Prenetics Global Ltd (0001876431) (Issuer)
- SECAmendment: SEC Form 20-F/A filed by Prenetics Global Limited20-F/A - Prenetics Global Ltd (0001876431) (Filer)
- PRPrenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 secondsPrenetics raises full-year 2026 IM8 revenue guidance to $210–220 million, up from $190–210 millionIM8 expected to reach $300 million in annualized run-rate revenue by year-end 2026IM8 expected to deliver $400 million or more in full-year 2027 revenueEvery $1 invested in customer acquisition has returned $1.44 in gross profit, blended across all mature cohorts NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading consume
- SECSEC Form 6-K filed by Prenetics Global Limited6-K - Prenetics Global Ltd (0001876431) (Filer)
- INSIDERSEC Form 3 filed by new insider Rosin Brian J3 - Prenetics Global Ltd (0001876431) (Issuer)
- INSIDERDirector Leogrande Hudson Blake converted options into 2,000 units of Class A Ordinary Share (SEC Form 4)4 - Prenetics Global Ltd (0001876431) (Issuer)
- SECAmendment: SEC Form 20-F/A filed by Prenetics Global Limited20-F/A - Prenetics Global Ltd (0001876431) (Filer)
- INSIDERDirector Cheng Yin Pan converted options into 15,873 units of Class A Ordinary Share (SEC Form 4)4 - Prenetics Global Ltd (0001876431) (Issuer)
- INSIDERDirector Vanderveen David converted options into 6,944 units of Class A Ordinary Share, increasing direct ownership by 18% to 45,249 units (SEC Form 4)4 - Prenetics Global Ltd (0001876431) (Issuer)
- ANALYSTThe Benchmark Company initiated coverage on Prenetics Group Ltd. with a new price targetThe Benchmark Company initiated coverage of Prenetics Group Ltd. with a rating of Buy and set a new price target of $30.00
- INSIDERSEC Form 3 filed by new insider Leogrande Hudson Blake3 - Prenetics Global Ltd (0001876431) (Issuer)
- SECSEC Form 6-K filed by Prenetics Global Limited6-K - Prenetics Global Ltd (0001876431) (Filer)
PRE FAQ
5 questionsWhere does PRE stock trade?
Prenetics Global Limited (PRE) is listed on NYSE.What sector and industry is PRE in?
Prenetics Global Limited operates in the Finance sector, Blank Checks industry.What are analysts saying about PRE?
Prenetics Global Limited has had 5 recent analyst actions on file. The most recent action was from The Benchmark Company: Buy with a $3000.00 price target on 2026-06-16.What companies are similar to PRE?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare PRE side-by-side with any of them on Quantisnow.How can I track PRE on Quantisnow?
Quantisnow aggregates Prenetics Global Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRE to receive live email and push alerts on every new disclosure.